Secondary outcomes
migraine, postoperative epilepsy, headache, seizure
MIGRAINE, ADVERSE EVENTS, COMPLICATIONS
Secondary efficacy outcomes include the percentage decrease in the average seizure duration per week during the postoperative 48 weeks compared to the preoperative period, improvement in postoperative epilepsy severity, frequency of epileptiform discharge by 24 h video EEG, evaluation of postoperative quality of life, improvement in migraine in patients with migraine complications, headache impact test, incidence rate of adverse events, cardiac ultrasound index, and laboratory indicators.